Medicenna Therapeutics Corp.
MDNAF· OTC
Quarterly figures for Medicenna Therapeutics Corp., with source filings when available.
3 quarters. Mar 31, 2021 to Mar 31, 2023. mixed units.
Filing lag not yet established. Fewer than two comparable filings are on file.
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2023 | |||||||||
| Q4 2023 | Mar 31, 2023 | — | — | — | |||||
Medicenna Therapeutics Corp. · CIK 1807983 · Engraved from SEC EDGAR
| — |
| — |
| — |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022 | Mar 31, 2022 | — | — | — | — | — | — | — | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021 | Mar 31, 2021 | — | — | — | — | — | — | — | |